Interaction ID
ncRI-40656659
Interaction Molecules
hsa-miR-551b-3p -- SPPL2A
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000138600
Description
Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in FASLG, ITM2B and TNF processing (PubMed:16829952, PubMed:16829951, PubMed:17557115, PubMed:17965014). Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus (PubMed:16829952). Also responsible for the intramembrane cleavage of Fas antigen ligand FASLG, which promotes the release of the intracellular FasL domain (FasL ICD) (PubMed:17557115). May play a role in the regulation of innate and adaptive immunity (PubMed:16829952). Catalyzes the intramembrane cleavage of the simian foamy virus envelope glycoprotein gp130 independently of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis (PubMed:23132852).
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-551b-3p | acute myeloid leukemia | MNDR Database |
hsa-miR-551b-3p | acute T cell leukemia | MNDR Database |
hsa-miR-551b-3p | Alzheimer's disease | MNDR Database |
hsa-miR-551b-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-551b-3p | autosomal recessive disease | MNDR Database |
hsa-miR-551b-3p | B-cell lymphoma | MNDR Database |
hsa-miR-551b-3p | biliary tract cancer | MNDR Database |
hsa-miR-551b-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-551b-3p | bone disease | MNDR Database |
hsa-miR-551b-3p | brain disease | MNDR Database |
hsa-miR-551b-3p | breast cancer | MNDR Database |
hsa-miR-551b-3p | Breast Neoplasms | MNDR Database |
hsa-miR-551b-3p | Burkitt lymphoma | MNDR Database |
hsa-miR-551b-3p | cancer | MNDR Database |
hsa-miR-551b-3p | carcinoma | MNDR Database |
hsa-miR-551b-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-551b-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-551b-3p | colon cancer | MNDR Database |
hsa-miR-551b-3p | colorectal cancer | MNDR Database |
hsa-miR-551b-3p | diabetes mellitus | MNDR Database |
hsa-miR-551b-3p | Ependymoma | MNDR Database |
hsa-miR-551b-3p | esophageal cancer | MNDR Database |
hsa-miR-551b-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-551b-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-551b-3p | Glioblastoma | MNDR Database |
hsa-miR-551b-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-551b-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-551b-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-551b-3p | large cell neuroendocrine cancer | MNDR Database |
hsa-miR-551b-3p | leukemia | MNDR Database |
hsa-miR-551b-3p | Liver Neoplasms | MNDR Database |
hsa-miR-551b-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-551b-3p | lung cancer | MNDR Database |
hsa-miR-551b-3p | lung disease | MNDR Database |
hsa-miR-551b-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-551b-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-551b-3p | lymphoma | MNDR Database |
hsa-miR-551b-3p | malignant glioma | MNDR Database |
hsa-miR-551b-3p | malignant pleural mesothelioma | MNDR Database |
hsa-miR-551b-3p | medulloblastoma | MNDR Database |
hsa-miR-551b-3p | melanoma | MNDR Database |
hsa-miR-551b-3p | multiple myeloma | MNDR Database |
hsa-miR-551b-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-551b-3p | neurodegenerative disease | MNDR Database |
hsa-miR-551b-3p | osteosarcoma | MNDR Database |
hsa-miR-551b-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-551b-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-551b-3p | pancreatic cancer | MNDR Database |
hsa-miR-551b-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-551b-3p | pituitary adenoma | MNDR Database |
hsa-miR-551b-3p | Precursor Cell Lymphoblastic Leukemia-Lymphoma | MNDR Database |
hsa-miR-551b-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-551b-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-551b-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-551b-3p | stomach cancer | MNDR Database |
hsa-miR-551b-3p | stomach carcinoma | MNDR Database |
hsa-miR-551b-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-551b-3p | synovial sarcoma | MNDR Database |
hsa-miR-551b-3p | thyroid cancer | MNDR Database |
hsa-miR-551b-3p | thyroid carcinoma | MNDR Database |
hsa-miR-551b-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-551b-3p | vascular disease | MNDR Database |